Literature DB >> 9526930

Droperidol-ondansetron combination versus droperidol alone for postoperative control of emesis after total abdominal hysterectomy.

T J Riley1, R McKenzie, B R Trantisira, D L Hamilton.   

Abstract

STUDY
OBJECTIVES: To investigate the hypothesis that the combination of ondansetron and droperidol would be more effective than droperidol alone in reducing nausea and vomiting.
DESIGN: Randomized, doubleblind study.
SETTING: Magee-Womens Hospital, Pittsburgh, Pennsylvania. PATIENTS: 160 healthy, ASA physical status I and II, female patients scheduled for total abdominal hysterectomy.
INTERVENTIONS: After induction of anesthesia with propofol, Group 1 received intravenous (i.v.) droperidol 1.25 mg plus i.v. ondansetron 4 mg. Group 2 received i.v. droperidol plus i.v. saline.
MEASUREMENTS AND MAIN RESULTS: The complete response (no emesis, no rescue) for Group 1 was 36 of 80 patients (45%) versus 30 of 80 patients (38%) in Group 2 (p = 0.21). In Group 1, 42 of 80 patients (53%) required rescue antiemetic as compared with 44 of 80 patients (55%) in Group 2 (p = 0.43). There were 72 total rescues in Group 1 versus 73 in Group 2, (p = 0.24). Mean time until first rescue was 578 +/- 429 minutes in Group 1 and 418 +/- 354 minutes in Group 2, (p = 0.03). In Group 1, 81 % (34/42) were rescued for nausea only versus 90% (39/44) of Group 2 (p = 0.16). In Group 1, 21% of patients (17/80) had at least one emetic episode versus 34% (27/80) of Group 2 patients (p = 0.05). There were 31 emetic episodes in Group 1 versus 72 episodes in Group 2. (p = 0.02). Mean time to the first emetic episode was 699 +/- 403 minutes in Group 1 and 616 +/- 376 minutes in Group 2, (p = 0.23).
CONCLUSION: For patients undergoing total abdominal hysterectomies, the addition of ondansetron to droperidol increases the time until first rescue and reduces the number of emetic episodes, as well as the percentage of patients, having at least one emetic episode.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526930     DOI: 10.1016/s0952-8180(97)00188-8

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  6 in total

Review 1.  Intravenous droperidol: a review of its use in the management of postoperative nausea and vomiting.

Authors:  Kate McKeage; Dene Simpson; Antona J Wagstaff
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  RETRACTED ARTICLE: Combination Antiemetic Regimens for Prevention of Postoperative Nausea and Vomiting : Focus on High-Risk Patients.

Authors:  Yoshitaka Fujii
Journal:  Clin Drug Investig       Date:  2002-09       Impact factor: 2.859

3.  Effects of Dexmedetomidine On the Postoperative Shivering, Nausea, and Vomiting Among Opium User Patients Undergoing Elective Supratentorial Brain Tumor Surgery: A Randomized, Placebo, Controlled Clinical trials.

Authors:  Rajabi Mona; Ommi Davood; Zali Alireza; Arefian Noor Mohammad
Journal:  Galen Med J       Date:  2021-11-19

4.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19

5.  Postoperative nausea and vomiting after thyroidectomy: a comparison between dexmedetomidine and remifentanil as part of balanced anesthesia.

Authors:  Eun Kyung Choi; Yijun Seo; Dong Gun Lim; Sungsik Park
Journal:  Korean J Anesthesiol       Date:  2017-03-15

6.  Effect of dexmedetomidine on prevention of postoperative nausea and vomiting in pediatric strabismus surgery: a randomized controlled study.

Authors:  Shuangshuang Li; Tingjie Liu; Junming Xia; Jie Jia; Wenxian Li
Journal:  BMC Ophthalmol       Date:  2020-03-05       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.